1. Home
  2. MLGO vs CRDL Comparison

MLGO vs CRDL Comparison

Compare MLGO & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLGO
  • CRDL
  • Stock Information
  • Founded
  • MLGO 2018
  • CRDL 2017
  • Country
  • MLGO China
  • CRDL Canada
  • Employees
  • MLGO N/A
  • CRDL N/A
  • Industry
  • MLGO EDP Services
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MLGO Technology
  • CRDL Health Care
  • Exchange
  • MLGO Nasdaq
  • CRDL Nasdaq
  • Market Cap
  • MLGO 104.2M
  • CRDL 90.4M
  • IPO Year
  • MLGO N/A
  • CRDL N/A
  • Fundamental
  • Price
  • MLGO $9.23
  • CRDL $1.17
  • Analyst Decision
  • MLGO
  • CRDL Strong Buy
  • Analyst Count
  • MLGO 0
  • CRDL 2
  • Target Price
  • MLGO N/A
  • CRDL $9.00
  • AVG Volume (30 Days)
  • MLGO 232.1K
  • CRDL 835.2K
  • Earning Date
  • MLGO 12-16-2025
  • CRDL 11-13-2025
  • Dividend Yield
  • MLGO N/A
  • CRDL N/A
  • EPS Growth
  • MLGO N/A
  • CRDL N/A
  • EPS
  • MLGO 4.04
  • CRDL N/A
  • Revenue
  • MLGO $61,302,336.00
  • CRDL N/A
  • Revenue This Year
  • MLGO N/A
  • CRDL N/A
  • Revenue Next Year
  • MLGO N/A
  • CRDL N/A
  • P/E Ratio
  • MLGO $2.39
  • CRDL N/A
  • Revenue Growth
  • MLGO N/A
  • CRDL N/A
  • 52 Week Low
  • MLGO $7.82
  • CRDL $0.77
  • 52 Week High
  • MLGO $972.00
  • CRDL $2.24
  • Technical
  • Relative Strength Index (RSI)
  • MLGO 45.20
  • CRDL 56.34
  • Support Level
  • MLGO $8.67
  • CRDL $1.14
  • Resistance Level
  • MLGO $9.99
  • CRDL $1.38
  • Average True Range (ATR)
  • MLGO 0.63
  • CRDL 0.08
  • MACD
  • MLGO -0.09
  • CRDL 0.02
  • Stochastic Oscillator
  • MLGO 26.92
  • CRDL 45.67

About MLGO MicroAlgo Inc.

MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: